Your browser doesn't support javascript.
loading
Corrigendum to "A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods" [Contemporary Clinical Trials 122 (2022) 1-11/106909].
Wronski, Marie-Louis; Plessow, Franziska; Kerem, Liya; Asanza, Elisa; O'Donoghue, Michelle L; Stanford, Fatima C; Bredella, Miriam A; Torriani, Martin; Soukas, Alexander A; Kheterpal, Arvin; Eddy, Kamryn T; Holmes, Tara M; Deckersbach, Thilo; Vangel, Mark; Holsen, Laura M; Lawson, Elizabeth A.
Afiliação
  • Wronski ML; Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Translational Developmental Neuroscience Section, Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, Dresden, Germany.
  • Plessow F; Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Kerem L; Division of Pediatric Endocrinology, Department of Pediatrics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Asanza E; Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • O'Donoghue ML; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Stanford FC; Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Division of Pediatric Endocrinology, Department of Pediatrics, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Bredella MA; Division of Musculoskeletal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Torriani M; Division of Musculoskeletal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Soukas AA; Center for Genomic Medicine, Diabetes Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Kheterpal A; Division of Musculoskeletal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Eddy KT; Eating Disorders Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Holmes TM; Translational and Clinical Research Centers, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Deckersbach T; Diploma Hochschule, University of Applied Sciences, Bad Sooden-Allendorf, Germany.
  • Vangel M; Biostatistics Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Holsen LM; Division of Women's Health, Department of Medicine and Department of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Lawson EA; Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: ealawson@mgh.harvard.edu.
Contemp Clin Trials ; 140: 107511, 2024 May.
Article em En | MEDLINE | ID: mdl-38522969
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article